Please login to the form below

Not currently logged in
Email:
Password:

AZ files Crestor patent lawsuits in US

AstraZeneca files patent infringement lawsuits against seven pharmaceutical companies that are attempting to market generic versions of its cholesterol-lowering blockbuster Crestor

UK-based pharmaceutical company, AstraZeneca (AZ), has filed patent infringement lawsuits against seven pharmaceutical companies that are attempting to market generic versions of its cholesterol blockbuster Crestor (rosuvastatin).

The lawsuits were filed in US District Court against the US-based companies Cobalt, Aurobindo Pharma, Par Pharmaceutical, Mylan Pharmaceuticals and Sun Pharmaceutical. Canada's Apotex and Germany's Sandoz International are also involved.

Crestor is AZ's third-best-selling treatment, with FY06 sales of USD 2bn. Shares in the company dropped in value by 0.9 per cent to reach GBP 22.77 (USD 46.58) in midday trading on 12 December 2007 in London.

12th December 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....

Infographics